The largest database of trusted experimental protocols

Stata se 14.2 for windows

Manufactured by StataCorp
Sourced in United States

Stata/SE 14.2 for Windows is a data analysis and statistical software package. It provides a comprehensive set of tools for data management, analysis, and visualization. The software is designed to handle large datasets and complex statistical models.

Automatically generated - may contain errors

Lab products found in correlation

10 protocols using stata se 14.2 for windows

1

Identifying Multiple Strain Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients’ biodata and the presence or absence of multiple strain infection results were entered and validated in Microsoft Excel® 2013. The data was then exported to Stata (Stata/SE 14.2 for windows, Stata Corp, College Station, TX) for statistical analysis. Chi-square test was used to compute proportions and determine the relationship between independent factors and dependent variables (presence multiple strain infection) with statistical significance considered at a 95% level of confidence. Since the feature of interest (multiple strain infections) was found in a small number of patients, an exact bivariate logistic regression analysis was performed to obtain odds ratios for factors that could be associated with the occurrence of multiple strains of M. tuberculosis among PTB patients in our setting. Exact logistic regression was selected because it calculates the conditional maximum chance of an event occurring within the sample population described by the model's varying factors. We did not specify a statistical significance threshold as per the recent statistical guidelines47 (link),48 .
+ Open protocol
+ Expand
2

Labor Force Dynamics in Population Survey

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistics were performed using frequencies and percentages.
Two-sample and paired t-tests were used for comparisons between
the groups of PSC and controls. All variables were stratified by gender.
Stata/SE 14.2 for Windows was used for the analyses. Tables and results from the
statistical analyses, confidence intervals and statistical significance, are
presented in Supplemental Tables IIIV.
We calculated the proportions of the total sample at the same time each year. All
data for variables labor-force participation, working hours,
and job changes were monitored every 12th month;
working hours and job changes were
dependent on labor-force participation. Significance level was
5%.
+ Open protocol
+ Expand
3

Mobility in Persons with Lower Limb Amputations

Check if the same lab product or an alternative is used in the 5 most similar protocols
The current observational study is part of a larger project examining mobility in persons with LLA. The Regional Committee for Medical and Health Research Ethics in Norway (2015/1245) approved the study which was performed according to the principles of the Declaration of Helsinki. All participants signed an informed consent prior to participation.
The main hypothesis was to investigate betweengroup comparisons. To identify the minimum sample size, an a priori power analysis was conducted based on walking speed (Wezenberg et al., 2013) (link). Power was set to 90%, alpha to .05 and power analysis (by Stata/SE 14.2 for Windows, College Station, TX, USA) estimated to a total sample size of 20. To increase the robustness of the analyses, a sample size of more than 30 persons in each group was considered appropriate.
+ Open protocol
+ Expand
4

Accuracy Evaluation of SARS-CoV-2 Diagnostic Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were assessed using STATA SE 14.2 for Windows (StataCorp LP, College Station, TX, USA) and MedCalc® Version 20.114 (MedCalc Software Ltd., Ostend, Belgium) software packages, with raw data being captured in Microsoft® Excel (Redmond, WA, USA). The positive percentage agreement (PPA), negative percentage agreement (NPA) [37 (link)], agreement (Cohen kappa [38 (link),39 ]) and precision compared to SOC (both tests) and Xpert® Xpress SARS-CoV-2 (Xpert® Xpress CoV-2 plus only) were calculated; 95 percent confidence intervals (95% CI) were included. Errors and invalid specimens were noted, and these results were excluded from the accuracy analysis.
+ Open protocol
+ Expand
5

Statistical Analysis of Microcarcinoma Characteristics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Summary statistics were reported as numbers (percentages) or mean ± standard deviation. Categorical variables were analyzed with the X2 test or the Fisher exact test, as appropriate. Continuous variables were compared between groups using the Student t test or one-way analysis of variance and Bonferroni multiple-comparison test. Univariate and multivariate conditional logistic regression models were performed in order to analyze the relationship between variables and mPTC groups. Conditional logistic regression models were conducted on pertinent clinicopathologic variables that reached p < 0.2 at univariate analysis. Model building followed a backward-stepwise approach, and the test of term significance was the Wald chi-square test.
Stata SE 14.2 for Windows (StataCorpLp, College Station, TX, USA) and GraphPad Prism, (GraphPad Software, San Diego, CA, USA) software were used for statistical analyses. All p values refer to two-tailed tests of significance; p < 0.05 was considered statistically significant.
+ Open protocol
+ Expand
6

Statistical Analysis of Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confidence intervals are reported as per the method of Louis and Zeger.21 (link) A p value of 0.05 was considered significant. All analyses were performed using Stata 14.2/SE for Windows (College Station, Texas).
+ Open protocol
+ Expand
7

Statistical Analysis of Confidence Intervals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confidence intervals are reported as per the method of Louis and Zeger.20 (link) An α of 0.05 was set for statistical significance. All analyses were performed using Stata 14.2/SE for Windows (College Station, Texas).
+ Open protocol
+ Expand
8

Post-Donation Kidney Function and Graft Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For descriptive purposes, post-donation eGFR above or below 60 mL/min per 1.73m2 was selected for its clinical relevance. For Kaplan-Meier curves of cumulative incidence of graft loss, we used quartiles of post-donation eGFR to demonstrate trends. For regression analysis, post-donation eGFR was examined as a continuous variable scaled per 10 mL/min. Fractional polynomial regression models were compared to models that included eGFR as a scaled linear variable; for both ACGF and DCGF, the models with eGFR as a linear variable had the better fit by AIC. Confidence intervals are reported as per the method of Louis and Zeger (19 ). All analyses were performed using Stata 14.2/SE for Windows (College Station, Texas).
+ Open protocol
+ Expand
9

Statistical Analysis of Research Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistics are reported using t tests, chi-square tests, and Pearson’s correlation coefficient. An α of 0.05 was considered significant. Confidence intervals are reported as per the method of Louis and Zeger [40 ]. Analyses were performed using Stata 14.2/SE for Windows (College Station, Texas).
+ Open protocol
+ Expand
10

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive comparisons were made with t-tests, chi-square tests, and analysis of variance (ANOVA), as appropriate. We used a two-sided α of 0.05 to indicate a statistically significant difference. Statistical analysis was performed using Stata 14.2/SE for Windows (College Station, Texas).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!